Lateral flow tests, or antigen tests, are the rapid tests which tell people whether or not they have coronavirus. People faced problems getting hold of the tests last week after a huge surge in demand ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

Agreement secures rapid, global access to tests for future pandemics and health emergencies Under the agreement, Roche gains access to at least 1 billion tests annually from Sapphiros' 5 billion unit ...